• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伴有组织学分级进展的复发性去分化脂肪肉瘤:一例报告

Recurrent dedifferentiated liposarcoma with histological grade progression: a case report.

作者信息

Giraldo Samuel Santiago Parra, López Rut Amparo Vergara, Hoz-Herazo Haydee De La, Pla Enrique Carlos Ruiz, Bayona-Pacheco Brayan, De La Hoz Juan Jose Espitia

机构信息

Division of Health Sciences, Department of Medicine, Universidad del Norte, Barranquilla 081007, Colombia.

Unidad de Patología Diagnostica UPC, Barranquilla 080001, Colombia.

出版信息

Ecancermedicalscience. 2025 Jan 22;19:1831. doi: 10.3332/ecancer.2025.1831. eCollection 2025.

DOI:10.3332/ecancer.2025.1831
PMID:40177153
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11959119/
Abstract

INTRODUCTION

Dedifferentiated liposarcoma (DDLPS) is a rare mesenchymal neoplasm that accounts for approximately 20% of soft tissue sarcomas in the human body. This case report emphasises a high-grade DDLPS with a retroperitoneal location and its unexpected recurrence in a 72-year-old male patient more than 10 years after the primary tumour. This case is particularly significant because of the anomalous presentation of the tumour recurrence time that is complemented by the unusual histologic features of the initial neoplasm, which raises new questions about the biological behaviour of the disease, the clinical course and the management of this pathology.

EXPECTED RESULTS

The report seeks to highlight the important and unusual aspects of the pathology that can contribute to a better understanding of its evolution, allowing informed clinical decisions to improve the patient's quality of life and prognosis.

摘要

引言

去分化脂肪肉瘤(DDLPS)是一种罕见的间叶性肿瘤,约占人体软组织肉瘤的20%。本病例报告着重介绍了一名72岁男性患者,其原发性肿瘤发生10多年后,出现了一例位于腹膜后的高级别DDLPS及其意外复发情况。该病例尤为重要,因为肿瘤复发时间异常,且初始肿瘤具有不寻常的组织学特征,这引发了关于该疾病生物学行为、临床病程及病理处理的新问题。

预期结果

本报告旨在突出该病理学的重要且不寻常的方面,有助于更好地理解其演变过程,从而做出明智的临床决策,以提高患者的生活质量和预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/face/11959119/124d65c50189/can-19-1831fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/face/11959119/3cd193c17340/can-19-1831fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/face/11959119/30077091a028/can-19-1831fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/face/11959119/f395be38e78c/can-19-1831fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/face/11959119/124d65c50189/can-19-1831fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/face/11959119/3cd193c17340/can-19-1831fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/face/11959119/30077091a028/can-19-1831fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/face/11959119/f395be38e78c/can-19-1831fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/face/11959119/124d65c50189/can-19-1831fig4.jpg

相似文献

1
Recurrent dedifferentiated liposarcoma with histological grade progression: a case report.伴有组织学分级进展的复发性去分化脂肪肉瘤:一例报告
Ecancermedicalscience. 2025 Jan 22;19:1831. doi: 10.3332/ecancer.2025.1831. eCollection 2025.
2
Whole exome sequencing of well-differentiated liposarcoma and dedifferentiated liposarcoma in older woman: a case report.老年女性高分化脂肪肉瘤和去分化脂肪肉瘤的全外显子组测序:病例报告
Front Med (Lausanne). 2023 Aug 15;10:1237246. doi: 10.3389/fmed.2023.1237246. eCollection 2023.
3
Survival of a patient with multiple-recurrent giant retroperitoneal dedifferentiated liposarcoma for 15 years: A case report.一名复发性巨大腹膜后去分化脂肪肉瘤患者生存15年:病例报告
Front Surg. 2022 Nov 7;9:916802. doi: 10.3389/fsurg.2022.916802. eCollection 2022.
4
Variability in recurrent retroperitoneal liposarcomas: A case series exploring histological subtypes.复发性腹膜后脂肪肉瘤的变异性:一项探索组织学亚型的病例系列研究。
Int J Surg Case Rep. 2025 Apr 12;131:111284. doi: 10.1016/j.ijscr.2025.111284.
5
Predictors of outcomes in patients with primary retroperitoneal dedifferentiated liposarcoma undergoing surgery.原发性腹膜后去分化脂肪肉瘤患者手术治疗结局的预测因素。
J Am Coll Surg. 2014 Feb;218(2):206-17. doi: 10.1016/j.jamcollsurg.2013.10.009. Epub 2013 Oct 25.
6
Paratesticular Dedifferentiated Liposarcoma with Epithelioid Features: A Diagnostic Pitfall.附睪去分化脂肪肉瘤伴上皮样特征:诊断陷阱。
Int J Surg Pathol. 2023 Aug;31(5):721-727. doi: 10.1177/10668969221120780. Epub 2022 Sep 15.
7
Application of MDM2 Fluorescence In Situ Hybridization and Immunohistochemistry in Distinguishing Dedifferentiated Liposarcoma From Other High-grade Sarcomas.MDM2荧光原位杂交和免疫组织化学在鉴别去分化脂肪肉瘤与其他高级别肉瘤中的应用
Appl Immunohistochem Mol Morphol. 2017 Nov/Dec;25(10):712-719. doi: 10.1097/PAI.0000000000000365.
8
What Are the Results of Resection of Localized Dedifferentiated Liposarcomas in the Extremities?肢体局限性去分化脂肪肉瘤切除的结果如何?
Clin Orthop Relat Res. 2020 Nov;478(11):2550-2561. doi: 10.1097/CORR.0000000000001338.
9
Dedifferentiated liposarcoma (DDLPS) in the rectum: A case report.直肠去分化脂肪肉瘤(DDLPS):一例报告。
J Int Med Res. 2022 Jun;50(6):3000605221102081. doi: 10.1177/03000605221102081.
10
Correlation of histological grade of dedifferentiation with clinical outcome in 55 patients with dedifferentiated liposarcomas.55例去分化脂肪肉瘤患者去分化组织学分级与临床结局的相关性
Hum Pathol. 2017 Aug;66:86-92. doi: 10.1016/j.humpath.2017.02.015. Epub 2017 Mar 12.

本文引用的文献

1
Genomic alterations and clinical outcomes in patients with dedifferentiated liposarcoma.去分化脂肪肉瘤患者的基因组改变与临床结局。
Cancer Med. 2023 Mar;12(6):7029-7038. doi: 10.1002/cam4.5502. Epub 2022 Dec 4.
2
Targeting the MDM2-p53 pathway in dedifferentiated liposarcoma.靶向去分化脂肪肉瘤中的MDM2-p53信号通路。
Front Oncol. 2022 Nov 10;12:1006959. doi: 10.3389/fonc.2022.1006959. eCollection 2022.
3
Biology and Management of Dedifferentiated Liposarcoma: State of the Art and Perspectives.去分化脂肪肉瘤的生物学特性与管理:现状与展望
J Clin Med. 2021 Jul 22;10(15):3230. doi: 10.3390/jcm10153230.
4
Dedifferentiated Liposarcoma: A Comprehensive Historical Review With Proposed Evidence-based Guidelines Regarding a Diagnosis in Need of Further Clarification.去分化脂肪肉瘤:全面的历史回顾及对进一步明确诊断需求的循证建议。
Adv Anat Pathol. 2021 Nov 1;28(6):426-438. doi: 10.1097/PAP.0000000000000314.
5
Long-Term Survival of a Patient with Recurrent Dedifferentiated High-Grade Liposarcoma of the Retroperitoneum Under Adjuvant Treatment with L. Extract: A Case Report.辅助治疗下复发性去分化高级腹膜后脂肪肉瘤患者的长期生存:病例报告。
Integr Cancer Ther. 2021 Jan-Dec;20:1534735421995258. doi: 10.1177/1534735421995258.
6
[Preoperative radiotherapy plus resection versus surgery alone in patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicenter randomized phase III study].[原发性腹膜后肉瘤患者术前放疗加手术切除与单纯手术的比较(EORTC-62092:STRASS):一项多中心随机III期研究]
Strahlenther Onkol. 2021 Mar;197(3):264-265. doi: 10.1007/s00066-020-01734-5. Epub 2021 Jan 5.
7
Integrated exome and RNA sequencing of dedifferentiated liposarcoma.去分化脂肪肉瘤的外显子组和 RNA 测序整合分析。
Nat Commun. 2019 Dec 12;10(1):5683. doi: 10.1038/s41467-019-13286-z.
8
Well-differentiated liposarcoma and dedifferentiated liposarcoma: An updated review.高分化脂肪肉瘤和去分化脂肪肉瘤:最新综述。
Semin Diagn Pathol. 2019 Mar;36(2):112-121. doi: 10.1053/j.semdp.2019.02.006. Epub 2019 Feb 28.
9
Role of chemotherapy in dedifferentiated liposarcoma of the retroperitoneum: defining the benefit and challenges of the standard.腹膜后去分化脂肪肉瘤的化疗作用:明确标准的获益和挑战。
Sci Rep. 2017 Sep 19;7(1):11836. doi: 10.1038/s41598-017-12132-w.
10
Dedifferentiated Liposarcoma: Updates on Morphology, Genetics, and Therapeutic Strategies.去分化脂肪肉瘤:形态学、遗传学及治疗策略的最新进展
Adv Anat Pathol. 2016 Jan;23(1):30-40. doi: 10.1097/PAP.0000000000000101.